Both in Pharmaceuticals
Medicinova vs Acrivon Therapeutics
Over the past year MNOV returned −4.0% and ACRV returned −30.9%; their daily moves had a correlation of -0.01.
MNOV −4.0% ACRV −30.9%Growth of $1, one year, split-adjusted
| Metric | MNOV | ACRV |
|---|---|---|
| Price | $1.44 | $1.61 |
| Market cap | $70.9M | $69.0M |
| Today | +2.86% | −3.01% |
| 1 month | −19.1% | −19.1% |
| 6 months | +2.9% | −25.8% |
| Year to date | +9.9% | −33.2% |
| 1 year | +21.0% | −17.0% |
| Revenue growth (YoY) | +240.6% | — |
| Gross margin | 100.0% | — |
| Net margin | −504.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 77.0× | — |
| Net cash | $25.4M | $90.0M |
| Dividend yield | — | — |
| Volatility (60d) | 114.5% | 70.2% |
| Short % of float | 0.7% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).